The absence of Brazilian national data on the determinants of clinical intensive insulin therapeutic regimen (IT) used by patients with T1D led the BrazDiab1SG to conduct this study to provide current and reliable data on this topic. This evidence concerns the gene INS and type 1 diabetes mellitus.